TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30656849

Group type: EXPERIMENTAL
Intervention: Ethanol treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PTEN inhibition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ethanol stimulation
Number of subjects: 0
Study: 28939223

Group type: EXPERIMENTAL
Intervention: Stereotactic radiosurgery (SRS)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Stereotactic radiosurgery (SRS) + Whole-brain radiation therapy (WBRT)
Number of subjects: 126
Study: 26319134

Group type: EXPERIMENTAL
Intervention: Vitamin D (4000 IE/day for 1 year)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study: 23617135

Group type: EXPERIMENTAL
Intervention: Manipulation of move, adduction, rotation method
Number of subjects: 120

Group type: COMPARATOR
Intervention: Traditional restoration methods with traction treatment
Number of subjects: 120
Study: 21196073

Group type: EXPERIMENTAL
Intervention: Subinguinal microsurgical varicocelectomy (TA)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Observation (CA)
Number of subjects: 145
Study: 18547177

Group type: EXPERIMENTAL
Intervention: NASHA 100,000 gel particles/mL filler with retreatment at 4.5 months
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: NASHA 100,000 gel particles/mL filler with retreatment at 9 months
Number of subjects: 75
Study: 16481296

Group type: EXPERIMENTAL
Intervention: Zeus robot-assisted laparoscopic cholecystectomy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional laparoscopic cholecystectomy
Number of subjects: 40
Study: 12930476

Group type: EXPERIMENTAL
Intervention: Flashbulb memories
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Everyday memories
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Initial visceral emotion ratings
Number of subjects: 54
Study: 11380216

Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation (PCI)
Number of subjects: 0
Study: 9778135

Group type: EXPERIMENTAL
Intervention: PALM‐diet
Number of subjects: 27

Group type: COMPARATOR
Intervention: TRANS‐diet
Number of subjects: 27

Group type: COMPARATOR
Intervention: PUFA‐diet
Number of subjects: 27
Study: 7871380

Group type: EXPERIMENTAL
Intervention: Omeprazole treatment for 14 days
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Triple therapy (bismuth subnitrate, oxytetracycline, metronidazole) for 2 weeks
Number of subjects: 51
Study: 3370308

Group type: EXPERIMENTAL
Intervention: Furosemide 40 mg as aqueous solution
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Furosemide 40 mg as Tablet A (fast dissolution)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Furosemide 40 mg as Tablet B (slow dissolution)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Furosemide tablets (both A and B)
Number of subjects: 21
Study: 31477643

Group type: EXPERIMENTAL
Intervention: Levetiracetam (20 mg/kg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Phenobarbitone (20 mg/kg)
Number of subjects: 100
Study: 28371433

Group type: EXPERIMENTAL
Intervention: Urine alpha 1 microglobulin (α1m)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Monocyte chemoattractant protein‐1 (MCP‐1)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Procollagen type I (PINP)
Number of subjects: 300
Study: 26860016

Group type: EXPERIMENTAL
Intervention: Lactated Ringer's solution (LRS)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch (HES)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Lactated Ringer's solution at a 'keep vein open' rate (Group E)
Number of subjects: 90
Study: 23325481

Group type: EXPERIMENTAL
Intervention: Trospium chloride XR 60 mg once daily for 10 days plus metformin 500 mg twice daily for 3.5 days
Number of subjects: 44

Group type: COMPARATOR
Intervention: Metformin 500 mg twice daily for 3.5 days
Number of subjects: 44

Group type: COMPARATOR
Intervention: Trospium chloride XR 60 mg once daily for 10 days
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Trospium chloride XR and metformin coadministration
Number of subjects: 44
Study: 21295937

Group type: EXPERIMENTAL
Intervention: Empathic statements by the interviewer
Number of subjects: 48
Study: 19858754

Group type: EXPERIMENTAL
Intervention: Dynamic Muscular Stabilization Techniques (DMST)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional treatment (electrotherapies and lumbar strengthening exercises)
Number of subjects: 30
Study: 16916771

Group type: EXPERIMENTAL
Intervention: Distance learning programme for general practitioners
Number of subjects: 187

Group type: COMPARATOR
Intervention: Written guidelines (Control)
Number of subjects: 187
Study: 15205566

Group type: EXPERIMENTAL
Intervention: 600 mg/day vaginal micronized progesterone (group I)
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol 100 microg/day + 600 mg/day vaginal micronized progesterone (group II)
Number of subjects: 252
Study: 11502994

Group type: EXPERIMENTAL
Intervention: Losartan (50 mg/day) for 8 weeks
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Enalapril (10 mg/day) for 8 weeks
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Losartan (50 mg/day)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Enalapril (10 mg/day)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 27
Study: 9113812

Group type: EXPERIMENTAL
Intervention: Cisapride 20 mg tid
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Cisapride 10 mg tid
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study: 8256900

Group type: EXPERIMENTAL
Intervention: Corticosteroid (CS) therapy with methylprednisolone
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 48
Study: 3839972

Group type: EXPERIMENTAL
Intervention: 2 g sucralfate twice a day
Number of subjects: 80

Group type: COMPARATOR
Intervention: 1 g sucralfate four times a day
Number of subjects: 80
Study: 31867844

Group type: EXPERIMENTAL
Intervention: Keratoconus health expenditure questionnaire
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Keratoconus prevalence data application
Number of subjects: 100
Study: 29775886

Group type: EXPERIMENTAL
Intervention: Sprint Interval Training (SIT)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Continuous Aerobic Training (CAT)
Number of subjects: 59
Study: 26002952

Group type: EXPERIMENTAL
Intervention: ASSQ (Athlete Sleep Screening Questionnaire)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Existing sleep-screening tools
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ASSQ
Number of subjects: 60
Study: 25085406

Group type: EXPERIMENTAL
Intervention: PharmD‐PCP MTM group
Number of subjects: 166

Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 166
Study: 22645114

Group type: EXPERIMENTAL
Intervention: Endoscopic DCR with mitomycin C (0.5 mg/mL applied for 10 minutes)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Endoscopic DCR without mitomycin C
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Endoscopic DCR with mitomycin C
Number of subjects: 76
Study: 20728414

Group type: EXPERIMENTAL
Intervention: Acupuncture as part of a Traditional Chinese Medicine (TCM) package
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acupuncture as a monotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alarm therapy
Number of subjects: 0
Study: 17919550

Group type: COMPARATOR
Intervention: PHX1149 single-dose (50 to 500 mg)
Number of subjects: 58

Group type: COMPARATOR
Intervention: PHX1149 multiple-dose (50 to 400 mg QD for 13 days)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 16053461

Group type: EXPERIMENTAL
Intervention: Sertraline (20 mg/day)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Alprazolam (1-1.5 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 12352513

Group type: EXPERIMENTAL
Intervention: Standard formula with a protein/energy ratio of 2.2 g/100 kcal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Formula with a protein/energy ratio of 1.8 g/100 kcal
Number of subjects: 0

Group type: COMPARATOR
Intervention: Breast-fed infants
Number of subjects: 0
Study: 10597955

Group type: EXPERIMENTAL
Intervention: Folic acid supplement 1.0 mg
Number of subjects: 8184

Group type: EXPERIMENTAL
Intervention: Folic acid supplement 2.5 mg
Number of subjects: 8184

Group type: COMPARATOR
Intervention: No folic acid supplement
Number of subjects: 8184
Study: 10075964

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg/day
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: UDCA 10 mg/kg/day
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Combination of simvastatin and UDCA
Number of subjects: 18
Study: 1992600

Group type: EXPERIMENTAL
Intervention: nilutamide (Anandron), 100 mg t.i.d. with orchiectomy
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: nilutamide (Anandron) plus orchiectomy
Number of subjects: 203

Group type: COMPARATOR
Intervention: orchiectomy alone
Number of subjects: 203
Study: 6188570

Group type: EXPERIMENTAL
Intervention: N-acetylprocainamide (NAPA)
Number of subjects: 4
Study: 30764655

Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 0
Study: 29383982

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 312

Group type: COMPARATOR
Intervention: Usual treatment (Control)
Number of subjects: 312
Study: 27004529

Group type: EXPERIMENTAL
Intervention: Continue co-trimoxazole prophylaxis
Number of subjects: 969

Group type: COMPARATOR
Intervention: Stop co-trimoxazole prophylaxis
Number of subjects: 969
Study: 25574984

Group type: EXPERIMENTAL
Intervention: Midazolam (0.05 mg/kg)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Propofol (0.4 mg/kg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Normal Saline (3 ml)
Number of subjects: 120
Study: 22491350

Group type: EXPERIMENTAL
Intervention: Acute alcohol administration (0.8 g/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 40
Study: 20389159

Group type: EXPERIMENTAL
Intervention: Sirolimus, low-dose tacrolimus, and steroids (Group A)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sirolimus, mycophenolate mofetil, and steroids (Group B)
Number of subjects: 24
Study: 18336747

Group type: EXPERIMENTAL
Intervention: Monofilament polypropylene mesh
Number of subjects: 32

Group type: COMPARATOR
Intervention: Multifilament polypropylene mesh
Number of subjects: 32
Study: 15632669

Group type: EXPERIMENTAL
Intervention: Walking with the exercise assist device
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Walking at approximately 60% VO(2max)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sitting
Number of subjects: 15
Study: 12457449

Group type: EXPERIMENTAL
Intervention: Dual-fortified salt (iodine 25 microg/g salt and iron 1 mg/g salt)
Number of subjects: 377

Group type: COMPARATOR
Intervention: Iodized salt (25 microg iodine/g salt)
Number of subjects: 377
Study: 10334396

Group type: EXPERIMENTAL
Intervention: Patients with brainstem lesions
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3
Study: 8596499

Group type: EXPERIMENTAL
Intervention: Resistance exercise training (RE)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Resistance exercise training (RE) + recombinant human growth hormone (rhGH)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Resistance exercise training (RE) + rhGH
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Resistance exercise training (RE) or hormone treatment
Number of subjects: 15
Study: 1749302

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with folinic acid, 5-Fluorouracil (FU) and mitomycin C (MMC)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control arm (not specified)
Number of subjects: 96
Study: 7044606

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 686

Group type: COMPARATOR
Intervention: Control (Medical treatment)
Number of subjects: 686
Study: 30817778

Group type: EXPERIMENTAL
Intervention: Plasma NGAL at Day 1
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Timed urine output
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: All biomarkers measured at Day 1 (except urinary L-FABP)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Early biomarker levels
Number of subjects: 225
Study: 28183345

Group type: EXPERIMENTAL
Intervention: Robot-assisted Single-Site™ cholecystectomy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Single-incision laparoscopic cholecystectomy
Number of subjects: 60
Study: 26341963

Group type: EXPERIMENTAL
Intervention: Cannabis derivatives
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Botanicals with anticonvulsant properties
Number of subjects: 0
Study: 23351826

Group type: EXPERIMENTAL
Intervention: Aborted myocardial infarction (AbMI)
Number of subjects: 5745

Group type: EXPERIMENTAL
Intervention: AbMI
Number of subjects: 5745
Study: 21308609

Group type: EXPERIMENTAL
Intervention: Hypertonic sodium chloride solution (3% NaCl)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Isotonic salt solution (0.9% NaCl)
Number of subjects: 20
Study: 19084860

Group type: EXPERIMENTAL
Intervention: Combined perianal‐intrarectal lidocaine‐prilocaine cream and periprostatic nerve block (group 1)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Perianal‐intrarectal lidocaine‐prilocaine cream alone (group 2)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Periprostatic nerve block alone (group 3)
Number of subjects: 280

Group type: COMPARATOR
Intervention: No anesthesia (group 4)
Number of subjects: 280
Study: 17463297

Group type: EXPERIMENTAL
Intervention: High sodium beverage (164 mmol Na(+)/l)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Low sodium beverage (10 mmol Na(+)/l)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Sodium loading (High Na(+))
Number of subjects: 13
Study: 15353052

Group type: EXPERIMENTAL
Intervention: Audiotape of GP consultation
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (no audiotape)
Number of subjects: 180
Study: 11786670

Group type: EXPERIMENTAL
Intervention: Various methods of evaluation (direct symptom outcomes, cumulative frequency distribution of threshold improvements, linear regression analysis of individual IPSS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard RCT methods (percentage of Symptom Index improvement)
Number of subjects: 0
Study: 9511777

Group type: EXPERIMENTAL
Intervention: Whirlpool bath at 40°C
Number of subjects: 6

Group type: COMPARATOR
Intervention: User-controlled water temperature (UCT)
Number of subjects: 6
Study: 7862806

Group type: EXPERIMENTAL
Intervention: Cognitively oriented pretreatment intervention
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 48
Study: 2074425

Group type: EXPERIMENTAL
Intervention: Ultrasonic device (Enac) at power level 1
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ultrasonic device (Enac) at power level 2
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ultrasonic device (Enac) at power level 3
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ultrasonic device (Enac) at power level 5
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hand instrumentation (Group E)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Uninstrumented controls (Group F)
Number of subjects: 60
Study: 7372352

Group type: EXPERIMENTAL
Intervention: Propranolol alone (P)
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Propranolol plus hydrochlorothiazide (P + T)
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Propranolol plus hydralazine (P + H)
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Reserpine plus hydrochlorothiazide (R + T)
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Propranolol plus hydrochlorothiazide plus hydralazine (P + T + H)
Number of subjects: 367
Study: 31361714

Group type: EXPERIMENTAL
Intervention: PA sedentary reduction (PASR) group
Number of subjects: 38

Group type: COMPARATOR
Intervention: Attention control (AC) group
Number of subjects: 38
Study: 31397121

Group type: EXPERIMENTAL
Intervention: Warming acupuncture combined with moxibustion at Yongquan (KI 1)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Simple warming acupuncture
Number of subjects: 66
Study: 28860046

Group type: EXPERIMENTAL
Intervention: IVB (2.5 mg/0.1 mL) administered 5-10 days before PPV (Group B)
Number of subjects: 156

Group type: COMPARATOR
Intervention: IVB (2.5 mg/0.1 mL) administered 1-3 days before PPV (Group A)
Number of subjects: 156
Study: 26448030

Group type: EXPERIMENTAL
Intervention: Interscalene brachial plexus block (ISBPB)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Supraclavicular brachial plexus block (SCBPB)
Number of subjects: 93
Study: 23347722

Group type: COMPARATOR
Intervention: Direct Laryngoscopy (DL)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: AirTraq
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: King LTS-D
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: GVL
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: CMAC
Number of subjects: 94
Study: 22939034

Group type: EXPERIMENTAL
Intervention: Linagliptin 5 mg once daily
Number of subjects: 245

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 245
Study: 18581160

Group type: EXPERIMENTAL
Intervention: Bioactive glass plus laser irradiation (40 mW, 4 J/cm², total energy density 16 J/cm²)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Bioactive glass only
Number of subjects: 20
Study: 17535636

Group type: EXPERIMENTAL
Intervention: Nutritional remedy with the dipeptide of glutamine and alanine (Group G)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Routine nutritional therapy only (Group C)
Number of subjects: 46
Study: 15070913

Group type: EXPERIMENTAL
Intervention: 20K-hGH 0.006 mg/kg.d
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: 20K-hGH 0.012 mg/kg.d
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: 20K-hGH 0.024 mg/kg.d
Number of subjects: 55
Study: 11472043

Group type: EXPERIMENTAL
Intervention: Invasive therapy
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Supervised physical training
Number of subjects: 253

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 253
Study: 9428488

Group type: EXPERIMENTAL
Intervention: Breast-conserving therapy (BCT) including excisional biopsy and postoperative external beam irradiation (45-50 Gy to the whole breast and a boost to the tumor bed to at least 60 Gy)
Number of subjects: 400
Study: 7527508

Group type: EXPERIMENTAL
Intervention: cICAM-1 levels in active MS patients
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: cICAM-1 levels at relapse
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: cTNF-R p60 levels in stable MS patients
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: cTNF-R p60 levels at relapse
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: cL-selectin levels in MS patients
Number of subjects: 29
Study: 2644999

Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Guanfacine
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 170
Study: 799976

Group type: EXPERIMENTAL
Intervention: Halcinonide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Betamethasone valerate
Number of subjects: 0
Study: 30225852

Group type: EXPERIMENTAL
Intervention: Lime powder regimen (LPR)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 28158558

Group type: EXPERIMENTAL
Intervention: Step Care intervention (single counseling session, nicotine patch for six weeks, telephonic contact)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Recycle intervention (one session of health behavior counseling, nicotine patch for six weeks, telephone call at each step)
Number of subjects: 270
Study: 23828089

Group type: EXPERIMENTAL
Intervention: Tenotomy
Number of subjects: 151

Group type: COMPARATOR
Intervention: Tenodesis
Number of subjects: 151
Study: 23413062

Group type: EXPERIMENTAL
Intervention: Mobile device (Apple fourth-generation iPod Touch)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Computer monitor (23-inch LCD)
Number of subjects: 93
Study: 21334613

Group type: EXPERIMENTAL
Intervention: recombinant FSH (50‐150 IU/d) plus ganirelix (0.25 mg/d)
Number of subjects: 93

Group type: COMPARATOR
Intervention: recombinant FSH (50‐150 IU/d) only
Number of subjects: 93
Study: 19860071

Group type: EXPERIMENTAL
Intervention: socioculturally adapted collaborative care depression management intervention
Number of subjects: 387

Group type: COMPARATOR
Intervention: not available
Number of subjects: 387
Study: 16951690

Group type: EXPERIMENTAL
Intervention: Filgrastim (5 microg/kg/day)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Lenograstim (5 microg/kg/day)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Molgramostim (5 microg/kg/day)
Number of subjects: 103
Study: 14755132

Group type: EXPERIMENTAL
Intervention: lamotrigine (300 mg per os)
Number of subjects: 19

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 19
Study: 11389707

Group type: EXPERIMENTAL
Intervention: lovastatin 20 mg/d
Number of subjects: 65

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 65
Study: 9268795

Group type: COMPARATOR
Intervention: Saline solution (Control)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Morphine sulfate (5 mg)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Bupivacaine (50 mg)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Combination of morphine sulfate and bupivacaine
Number of subjects: 105